An open-label phase 1 trial of the safety and efficacy of daily subcutaneous spl-108 injections in combination with paclitaxel in patients with platinum-resistant, CD44+, advanced ovarian epithelial cancer
Girda, E., De Meritens, A. Buckley, Leiser, A., Stephenson, R.D., Nelson, D., Rodriguez-Rodriguez, L.Volume:
154
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.218
Date:
June, 2019
File:
PDF, 267 KB
english, 2019